Premium
Fever and neutropenia outcomes and areas for intervention: A report from SUCCOUR ‐ Supportive Care for Children with Cancer in Africa
Author(s) -
Israels Trijn,
Afungchwi Glenn Mbah,
Klootwijk Larissa,
Njuguna Festus,
Hesseling Peter,
Kouya Francine,
Paintsil Vivian,
Landman Lisa,
Chitsike Inam,
Chagaluka George,
Sung Lillian,
Molyneux Elizabeth
Publication year - 2021
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.29224
Subject(s) - medicine , neutropenia , blood cancer , antibiotics , cancer , pediatrics , intensive care medicine , chemotherapy , microbiology and biotechnology , biology
Background Death during paediatric cancer treatment is common in sub‐Saharan Africa. Using the infrastructure of Supportive Care for Children with Cancer in Africa (SUCCOUR), our objective was to describe fever and neutropenia (FN) characteristics and outcomes in order to identify potential areas for future intervention. Methods A multicentre prospective, observational cohort study was conducted in sub‐Saharan Africa. Data were collected from September 2019 to March 2020. Children below 16 years with newly diagnosed cancer treated with curative intent were included. Data were abstracted in real time using standardised case report forms by trained personnel. Characteristics and outcomes of FN during the first 3 months of treatment were documented. Results A total of 252 patients were included (median age 6.0, range 0.2–15.0 years, 54% male). The most common cancer was Burkitt lymphoma (63/252, 25%). Among 104 FN episodes, 21 (21%) were associated with prolonged neutropenia (>1 week) and 32 (31%) were associated with profound neutropenia (absolute neutrophil count <0.1 × 10 9 /L). In 10/104 (10%) episodes, empiric antibiotics were started within 1 hour following fever onset and in 16/104 (15%) episodes, a blood culture was obtained before starting antibiotics. Malaria parasitaemia was detected in four of 104 (4%). A total of 11/104 (11%) patients died in the FN episodes. Conclusions Although in most, FN was not associated with prolonged or profound neutropenia, 11% resulted in death. Areas to target include blood cultures prior to antibiotics and earlier initiation of empiric antibiotics. Future efforts should modify FN practices to reduce treatment‐related mortality.